Cargando…
Improving hypertension control in patients at cardiovascular risk: the case for telmisartan-based therapy
Autor principal: | J, Aalbers |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Clinics Cardive Publishing
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053648/ https://www.ncbi.nlm.nih.gov/pubmed/21298207 |
Ejemplares similares
-
Angiotensin receptor blockers (ARBs) in hypertension patients: earlier use of these bettertolerated medications is warranted
por: Aalbers, J
Publicado: (2010) -
ARBs and risk of cancer: international and South African expert comment
Publicado: (2010) -
Disaster hypertension and cardiovascular events in disaster and COVID‐19 pandemic
por: Narita, Keisuke, et al.
Publicado: (2021) -
Measure Accurately, Act Rapidly, and Partner With Patients (MAP) improves hypertension control in medically underserved patients: Care Coordination Institute and American Medical Association Hypertension Control Project Pilot Study results
por: Hanlin, Robert B., et al.
Publicado: (2018) -
Benefits of Tight Blood Pressure Control in Diabetic Patients With Hypertension: Importance of early and sustained implementation of effective treatment strategies
por: Parati, Gianfranco, et al.
Publicado: (2011)